Mu-tong CHEN

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

First Affiliated Hospital of Shantou University Medical College(Current)

Cancer Hospital of Shantou University Medical College

Shantou Central Hospital

Shantou University Medical College

Shantou University

Mu-tong CHEN is an author at First Affiliated Hospital of Shantou University Medical College specializing in molecular oncology, oncology, and medicine.

Publications per year

2020–2021

Publications

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer

Yuanke Liang, Ze-kun- Deng, Mu-tong CHEN et al. · Frontiers in Oncology · 2021 · 62 citations · Full text

Medicine, Immunology, Oncology +17

FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer

Qin Xie, Yingsheng Xiao, Shicheng Jia et al. · Cancer Cell International · 2020 · 27 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–2 of 2